What is the address of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

The registered office of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is located at Rondenboslaan 3, 1652 Beersel.

Is DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE still active?

Yes. According to the CBE (18 September 2026) DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is active, legal situation “Normale toestand”, started on 10 November 2005.

Is DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE registered on Peppol?

Yes, DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is registered on the Peppol network with ID 0208:0877217619.

What is the enterprise number of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

The enterprise number of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is BE0877217619.

Who are the directors of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

According to the 2025 annual accounts, the directors of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE are: Inge Van der Heyden.

Is DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 November 2005; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE make in 2025?

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE posted a profit after taxes of € 127,964 in financial year 2025.

What is the revenue of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

As a small company, DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 183,400.

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE

Q: When was DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE founded?

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE was founded on 10 November 2005.

Dossier DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE, printed on 18 September 2026 from databakkes.be/en/0877217619/dr-van-der-heyden-inge-gynaecologie-verloskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE from Beersel, company number BE0877217619, closed financial year 2025 with a result of € 127,964 after tax. For that financial year DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE recorded a gross margin of € 183,400 and equity of € 588,602. Compared with financial year 2024, the result moved from € 109,558 to € 127,964. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.

What it is worth Growing

€ 588,602

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 127,964

▲ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 506,132

▲ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 70,899 paid out

55 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 7,596

▼ 56% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 2

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 1,521

▲ 293% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 1,000

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 143,414 Gross margin 2022: € 143,414 First fiscal year in the series	€ 159,679 Gross margin 2023: € 159,679 ▲ 11% vs 2022 (€ 143,414) Favourable step	€ 170,538 Gross margin 2024: € 170,538 ▲ 7% vs 2023 (€ 159,679) Favourable step	€ 183,400 Gross margin 2025: € 183,400 ▲ 8% vs 2024 (€ 170,538) Favourable step	▲ 8%
Profit after taxes	€ 85,536 Profit after taxes 2022: € 85,536 First fiscal year in the series	€ 99,412 Profit after taxes 2023: € 99,412 ▲ 16% vs 2022 (€ 85,536) Favourable step	€ 109,558 Profit after taxes 2024: € 109,558 ▲ 10% vs 2023 (€ 99,412) Favourable step	€ 127,964 Profit after taxes 2025: € 127,964 ▲ 17% vs 2024 (€ 109,558) Favourable step	▲ 17%
Equity	€ 557,794 Equity 2022: € 557,794 First fiscal year in the series	€ 570,873 Equity 2023: € 570,873 ▲ 2% vs 2022 (€ 557,794) Favourable step	€ 531,536 Equity 2024: € 531,536 ▼ 7% vs 2023 (€ 570,873) Unfavourable step	€ 588,602 Equity 2025: € 588,602 ▲ 11% vs 2024 (€ 531,536) Favourable step	▲ 11%
Total debts	€ 139,068 Total debts 2022: € 139,068 First fiscal year in the series	€ 136,212 Total debts 2023: € 136,212 ▼ 2% vs 2022 (€ 139,068) Favourable step	€ 187,910 Total debts 2024: € 187,910 ▲ 38% vs 2023 (€ 136,212) Unfavourable step	€ 237,508 Total debts 2025: € 237,508 ▲ 26% vs 2024 (€ 187,910) Unfavourable step	▲ 26%
Cash	€ 434,096 Cash 2022: € 434,096 First fiscal year in the series	€ 280,117 Cash 2023: € 280,117 ▼ 35% vs 2022 (€ 434,096) Unfavourable step	€ 397,377 Cash 2024: € 397,377 ▲ 42% vs 2023 (€ 280,117) Favourable step	€ 506,132 Cash 2025: € 506,132 ▲ 27% vs 2024 (€ 397,377) Favourable step	▲ 27%
Land & buildings	€ 103,165 Land & buildings 2022: € 103,165 First fiscal year in the series	€ 92,859 Land & buildings 2023: € 92,859 ▼ 10% vs 2022 (€ 103,165) Unchanged	€ 82,554 Land & buildings 2024: € 82,554 ▼ 11% vs 2023 (€ 92,859) Unchanged	€ 72,248 Land & buildings 2025: € 72,248 ▼ 12% vs 2024 (€ 82,554) Unchanged	▼ 12%
Retained profit	€ 483,394 Retained profit 2022: € 483,394 First fiscal year in the series	€ 496,473 Retained profit 2023: € 496,473 ▲ 3% vs 2022 (€ 483,394) Favourable step	€ 457,136 Retained profit 2024: € 457,136 ▼ 8% vs 2023 (€ 496,473) Unfavourable step	€ 514,202 Retained profit 2025: € 514,202 ▲ 12% vs 2024 (€ 457,136) Favourable step	▲ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 86,333 Dividend 2023: € 86,333 Unchanged (€ 0) Unchanged	€ 148,895 Dividend 2024: € 148,895 ▲ 72% vs 2023 (€ 86,333) Unchanged	€ 70,899 Dividend 2025: € 70,899 ▼ 52% vs 2024 (€ 148,895) Unchanged	▼ 52%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 2 Bank debt 2025: € 2 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 737,363 Balance sheet total 2022: € 737,363 First fiscal year in the series	€ 747,585 Balance sheet total 2023: € 747,585 ▲ 1% vs 2022 (€ 737,363) Unchanged	€ 759,946 Balance sheet total 2024: € 759,946 ▲ 2% vs 2023 (€ 747,585) Unchanged	€ 866,609 Balance sheet total 2025: € 866,609 ▲ 14% vs 2024 (€ 759,946) Unchanged	▲ 14%

Key figures of DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

What happened at DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 17, 2026 New annual accounts for financial year 2025: profit of € 127,964 (▲ 17% vs 2024). Source: NBB ↗
Nov 10, 2005 Start of the company according to the CBE. KBO
Oct 24, 2005 New establishment in Beersel. KBO

In short

From € 85,536 profit in 2022 to € 127,964 profit in 2025.

Paid € 167,878 in corporate taxes since 2022.

Best year ever: 2025, with € 127,964 profit.

Paid out € 306,127 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE? We notify you, reason included.

Follow DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Inge Van der Heyden

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE

Behind DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE is Inge Van der Heyden.

See the full network in the app

Directors

According to the 2025 annual accounts

Inge Van der Heyden

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rondenboslaan 3

1652 Beersel

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0877.217.619
VAT number: BE 0877.217.619
Registered office: Rondenboslaan 3, 1652 Beersel
Names & denominations: DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 November 2005
Peppol: Active · Active since 25 Nov 2025

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE

Financials

What happened to DR. VAN DER HEYDEN INGE,GYNAECOLOGIE-VERLOSKUNDE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions